Aptorum Group Limited (NASDAQ:APM – Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totalling 98,500 shares, a decrease of 23.6% from the March 15th total of 128,900 shares. Approximately 3.9% of the shares of the stock are sold short. Based on an average daily volume of 2,330,000 shares, the days-to-cover ratio is currently 0.0 days.
Aptorum Group Stock Performance
NASDAQ:APM traded down $0.36 during trading hours on Monday, hitting $7.85. The company’s stock had a trading volume of 48,170 shares, compared to its average volume of 2,135,791. The stock has a fifty day simple moving average of $5.46 and a 200-day simple moving average of $3.14. Aptorum Group has a twelve month low of $1.35 and a twelve month high of $17.49.
Institutional Trading of Aptorum Group
An institutional investor recently bought a new position in Aptorum Group stock. Citadel Advisors LLC bought a new stake in Aptorum Group Limited (NASDAQ:APM – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 37,106 shares of the company’s stock, valued at approximately $43,000. Citadel Advisors LLC owned about 0.10% of Aptorum Group at the end of the most recent quarter. Institutional investors own 3.80% of the company’s stock.
Aptorum Group Company Profile
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.
Further Reading
- Five stocks we like better than Aptorum Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- The Charles Schwab Company Can Hit New Highs
- How to Use the MarketBeat Dividend Calculator
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.